Last Seven Days

27 articles from the last seven days

• 
  Aussie staff let go as pharma put up for sale

  A Sydney-based pharma is up for sale, with almost the entire workforce wiped out, following the appointment of a Voluntary Administrator

  24 Sep 2026
• 
  Psychedelic medicines flying high

  Three years after Australia's world-first decision to permit the prescribing of psilocybin and MDMA, the sector is booming and Big Pharma's are making a play

  24 Sep 2026
• 
  Global genomics boss heading to Australia

  The Chief Scientific Officer for the NHS will visit Australia next month with a packed schedule including an address to the National Press Club

  24 Sep 2026
• 
  Speed bump ahead for NZ fast-track?

  New approvals pathway could put the country at risk of contravening an international trade agreement, according to lawyers

  24 Sep 2026
• 
  Pharma downsizes in Australia

  This company is downsizing its office space following the latest restructuring in Australia, with an official move slated for the start of next month

  24 Sep 2026
• 
  Drug slated for PBS delisting gets more time

  While manufacturing costs have gone up, reimbursement is less than half what it was when this drug was first listed but the PBAC still said 'No' to a price rise. Now plans to delist it from the PBS have been delayed by six months following a patient outcry

  23 Sep 2026
• 
  115 years on: First female CEO appointed

  This member-led organisation has appointed the first female CEO in its 115-year history, following a national recruitment drive

  23 Sep 2026
• 
  Changed global pricing environment sinks PBS listing

  The shortest line yet between America's MFN policy and a life-saving drug not being PBS listed has been drawn, with a company decrying the PBAC's unwillingness to adapt to a changed pricing environment

  23 Sep 2026
• 
  Nine pharmas seek to add new drug labels

  Nine pharmas hope to add new labels to their drugs in Australia in 2027 after the TGA accepted their applications for evaluation between June and July

  23 Sep 2026
• 
  And again... Keytruda challenger shapes up

  Another impressive trial win for Summit Therapeutics' challenger to the world's biggest drug has been branded a good omen for Big Pharmas in the same space

  23 Sep 2026
• 
  Lilly goes direct for non-PBS meds

  Faced with growing challenges to listing some drugs on the PBS, Lilly has launched a platform to facilitate dispensing and delivery of medications to a patient's door at more affordable prices

  22 Sep 2026
• 
  Novo unveils five multi-blockbuster plan

  Company details future mega revenue earners while also releasing topline results for its next star performer, which beat a rival Lilly drug in a head-to-head trial

  22 Sep 2026
• 
  10 innovative drugs land on TGA review desk

  Australia's medicines regulator has accepted an additional 10 Type A applications between June and July, with some pegged blockbusters making the list

  22 Sep 2026
• 
  Chilling forecast on future PBS spending

  The Federal Government's Intergenerational Report forecasts PBS spending will grow more slowly than health spending as a whole

  22 Sep 2026
• 
  Senior leadership shake-up sweeps industry

  There has a been a rush on senior leadership moves across industry with a string of departures, returns, company moves and internal promotions

  22 Sep 2026
• 
  Novo dragged into horror DV weekend

  Media reports of a spate of domestic violence homicides over the weekend included one accused's defence that he was affected by Ozempic.

  21 Sep 2026
• 
  Telix pays $3.3B to lock up the market

  The local giant has shored up isotope supply for its late-stage pipeline with the icing on the cake, acquiring a radiopharmaceutical on the cusp of winning FDA approval

  21 Sep 2026
• 
  Novel therapy heading to Australia

  Under an expanded deal, this company has snagged Australian rights to a new topical formulation of a well-known JAK inhibitor

  21 Sep 2026
• 
  Early October listings climb to four

  Health Minister Mark Butler announces another two October listings, one of which will benefit more than 143,000 Australians from the start of next month

  21 Sep 2026
• 
  TGA approves new flu jab

  A new vaccine has been approved by the TGA for adults along with new versions of drugs sponsored by Celltrion Healthcare, Kyowa Kirin, and UCB.

  21 Sep 2026